Bayer wins FDA approval for stroke prevention drug Sunharbo

Bayer’s asundexian won FDA approval to reduce the risk of stroke in people who recently had a mild-to-moderate non-cardioembolic ischemic stroke or a high-risk transient ischemic attack. The agency on Monday greenlit the drug in ...